Akso Health Group: stock overview

AHGNASDAQTechnology · Services-Business Services, NEC

Price

$1.24

November 20, 2026Market cap $896M

What Ploutos Investor adds for Akso Health

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 10 fiscal years, from FY2017
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

In short

Akso Health had revenue of $14M in the fiscal year to March 31, 2026 and a net loss of $19M. Revenue grew by 51.1% a year on average over the last 5 years. It holds more cash than debt, by $170.6K. It pays no dividend.

From its SEC filings (latest fiscal year to March 31, 2026) and the price of November 20, 2026.

Its SEC filings
Market cap
$896M
723M shares
P/E
–
Revenue, fiscal year
$14M
+51.1% a year over 5 years
Net margin
-135.0%

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

3 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

FY2024–FY2026 fiscal years

+139.4% a year over 2 years

  • FY2026Mar 31, 202620-F
    Revenue$14M
  • FY2025Mar 31, 202520-F
    Revenue$15M
  • FY2024Mar 31, 202420-F
    Revenue$2.4M

Fiscal years in figures

AHG's revenue, profit, cash flow and dividend with each year-end price, from FY2017 to FY2023, 7 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 3-year median: $651M
$896M
Enterprise value 
$896M
P/E 
–
EV / EBIT 
–
EV / Revenue 
64.8
P/B 3-year median: 3.3
5.0
FCF yield 
–
Earnings yield 3-year median: -18.1%
–

Profitability

Gross margin 
-0.1%
Operating margin 
-149.7%
Net margin 3-year median: -391.8%
-135.0%
ROIC 
-9.0%
ROIC, 5-year average 
-52.3%
ROE, fiscal year 
-10.3%

Growth

Revenue, yearly change 
-6.4%
EPS, yearly change 
–
FCF, yearly change 
-1,350.9%
Revenue, average a year 
+51.1%

The yearly change compares FY2026 with FY2025.

Balance sheet

Cash 
$170.6K
Total debt 
$25.1K
Of which operating leases 
$25.1K
Net cash 
$170.6K
Net debt / EBITDA 
–
Interest cover 
–
Current ratio 
–

Balance sheet of March 31, 2026.

Returns to shareholders

Dividend yield 
0.00%
Buybacks 
–
Total returned 
0.00%
Shares, yearly change 
+31.0%
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
Akso Health Group
Exchange
NASDAQ
Industry (SIC)
7389 · Services-Business Services, NEC
Fiscal year ends
March 31
Latest annual report
March 31, 2026
Reporting currency
USD
Shares
723M

Other companies: Technology

The largest companies of the same sector, each with its own page.

The Technology sectorAll companies

The full analysis

What do Akso Health's filings show?

These are Akso Health's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about AHG

Didn't find what you were looking for?

Ask us
What is AHG's market cap?

Akso Health Group's market cap is $896M, at a price of $1.24 on November 20, 2026 and 723M shares.

How much revenue does AHG have?

Akso Health had revenue of $14M in the fiscal year to March 31, 2026. Over the last 5 years it changed by +51.1% a year on average.

Does AHG pay a dividend?

No. Akso Health paid no regular dividend over the last 12 months.

Where do the figures come from?

From Akso Health Group's SEC filings (its annual report on 20-F) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.